[go: up one dir, main page]

HK1206975A1 - Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and or a sorbitan ester in the cosmetic treatment of cutaneous atopy - Google Patents

Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and or a sorbitan ester in the cosmetic treatment of cutaneous atopy

Info

Publication number
HK1206975A1
HK1206975A1 HK15107541.2A HK15107541A HK1206975A1 HK 1206975 A1 HK1206975 A1 HK 1206975A1 HK 15107541 A HK15107541 A HK 15107541A HK 1206975 A1 HK1206975 A1 HK 1206975A1
Authority
HK
Hong Kong
Prior art keywords
inhibition
adhesion
pathogenic microorganisms
sorbitan ester
cosmetic treatment
Prior art date
Application number
HK15107541.2A
Other languages
Chinese (zh)
Inventor
‧托雷爾
‧加托
Original Assignee
Thorel Jean Nol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thorel Jean Nol filed Critical Thorel Jean Nol
Publication of HK1206975A1 publication Critical patent/HK1206975A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Biomedical Technology (AREA)
HK15107541.2A 2012-08-07 2015-08-05 Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and or a sorbitan ester in the cosmetic treatment of cutaneous atopy HK1206975A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1257681A FR2994386B1 (en) 2012-08-07 2012-08-07 INHIBITION OF ADHESION OF PATHOGENIC MICROORGANISMS BY SUCROSE AND / OR SORBITAN ESTER IN THE COSMETIC TREATMENT OF SKIN ATOPIA
PCT/FR2013/051856 WO2014023895A2 (en) 2012-08-07 2013-07-31 Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and/or a sorbitan ester in the cosmetic treatment of cutaneous atopy

Publications (1)

Publication Number Publication Date
HK1206975A1 true HK1206975A1 (en) 2016-01-22

Family

ID=47022892

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107541.2A HK1206975A1 (en) 2012-08-07 2015-08-05 Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and or a sorbitan ester in the cosmetic treatment of cutaneous atopy

Country Status (10)

Country Link
EP (2) EP2882413B1 (en)
JP (2) JP6352261B2 (en)
KR (1) KR102059919B1 (en)
CN (1) CN104602668B (en)
CA (1) CA2881267C (en)
ES (2) ES2751878T3 (en)
FR (1) FR2994386B1 (en)
HK (1) HK1206975A1 (en)
PT (1) PT3246013T (en)
WO (1) WO2014023895A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016408394B2 (en) 2016-05-26 2021-11-11 Kimberly-Clark Worldwide, Inc. Anti-adherent compositions and methods of inhibiting the adherence of microbes to a surface
FR3065372B1 (en) * 2017-04-21 2019-12-20 Jean Noel Thorel COMPOSITION COMPRISING CARBOXY METHYL NARINGENINE CHALCONE FOR THE TREATMENT OF PRURITUS AND ATOPIC DERMATITIS
CN108524478B (en) * 2018-06-11 2020-05-08 四川昇嘉科技有限公司 Application of sanshool in preparation of external preparation for repairing skin photodamage
BR112021020495A2 (en) * 2019-05-16 2022-01-04 Unilever Ip Holdings B V Use of sugar or sugar alcohol for inhibiting the growth of harmful bacteria and method of inhibiting the growth of harmful bacteria
CN113509457B (en) * 2020-09-07 2023-03-21 四川昇嘉科技有限公司 Application of sanshool in preparation of medicine for treating eczema
KR20220083289A (en) 2020-12-11 2022-06-20 정기순 Drunk Driving Prevention System
FR3118416B1 (en) 2020-12-24 2023-11-17 Naos Inst Of Life Science COSMETIC COMPOSITION CAPABLE OF STRENGTHENING EPIDERMAL TIGHT JUNCTIONS FOR THE PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS
JPWO2022230925A1 (en) * 2021-04-28 2022-11-03

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01311014A (en) * 1988-06-06 1989-12-15 Taiyo Kagaku Co Ltd Antimicrobial skin drug for external use
NL1003524C2 (en) * 1996-07-05 1998-01-12 Cooperatie Cosun U A Diaper rash prevention or treatment composition.
US5961997A (en) * 1997-03-25 1999-10-05 Swinehart; James M. Antipruritic composition
DE19718777A1 (en) * 1997-05-03 1998-11-05 Beiersdorf Ag Use of esters from fatty acids and di- and oligosaccharides against the adhesion of microorganisms
FR2798591B1 (en) * 1999-09-22 2001-10-26 Pharmascience Lab USE OF A VEGETABLE OIL PRODUCT FOR INCREASING THE SYNTHESIS OF SKIN LIPIDS IN COSMETICS, PHARMACY OR DERMATOLOGY AND AS A FOOD ADDITIVE
JP2001181175A (en) * 1999-12-27 2001-07-03 Prosper & Company Kk Cosmetic and quasi-drug
US20030027786A1 (en) * 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
JP2003012492A (en) * 2001-07-02 2003-01-15 Noevir Co Ltd Cosmetic
JP2003089660A (en) * 2001-09-18 2003-03-28 Mitsubishi-Kagaku Foods Corp Method for preventing lotion from degeneration
EP1340486A1 (en) * 2002-03-01 2003-09-03 Cognis France S.A. Use of sugar esters
JP4509517B2 (en) * 2002-09-19 2010-07-21 ロート製薬株式会社 Agent that inhibits Staphylococcus aureus skin adhesion and promotes Staphylococcus epidermidis skin adhesion
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
WO2004037225A2 (en) * 2002-10-25 2004-05-06 Foamix Ltd. Cosmetic and pharmaceutical foam
TWI365075B (en) * 2004-09-22 2012-06-01 Kao Corp Microemulsion
WO2006134937A1 (en) * 2005-06-14 2006-12-21 Sekisui Chemical Co., Ltd. Skin preparation for external use
JP2007332055A (en) * 2006-06-13 2007-12-27 Sekisui Chem Co Ltd External preparation for skin
CN101468006B (en) * 2007-12-25 2011-12-28 重庆华邦制药股份有限公司 Compound pharmaceutical composition containing doxepin and nicotinic amide
KR20090108848A (en) * 2008-04-14 2009-10-19 주식회사 씨에이팜 Atopic Treatment Composition
WO2009128584A1 (en) * 2008-04-14 2009-10-22 C.A. Pharm Co., Ltd. The composition for the prevention and treatment of striae distensae and atopy
US20100080768A1 (en) * 2008-09-26 2010-04-01 Mcgraw Thomas L Compositions and Methods for the Treatment of Inflammatory Dermatosis and Other Pathological Conditions of the Skin
PL2210588T3 (en) * 2008-12-23 2011-09-30 Intendis Gmbh Foamable composition essentially free of pharmaceutically active ingredients for the treatment of human skin
DE102009022444A1 (en) * 2009-05-23 2010-01-07 Clariant International Limited Liquid composition, useful to preserve e.g. cream, comprises sorbitan monocaprylate and antimicrobial agent comprising organic acid and its salts, formaldehyde donor, isothiazolinone, paraben ester and its salts and pyridone and its salts
JP5594868B2 (en) * 2010-01-25 2014-09-24 株式会社ミルボン Hairdressing composition
FR2970177B1 (en) * 2011-01-11 2013-08-02 Oreal CLEANSING OILY COMPOSITION

Also Published As

Publication number Publication date
KR102059919B1 (en) 2019-12-27
WO2014023895A2 (en) 2014-02-13
EP2882413B1 (en) 2018-04-11
CN104602668B (en) 2018-12-28
FR2994386A1 (en) 2014-02-14
KR20150040909A (en) 2015-04-15
CN104602668A (en) 2015-05-06
JP6352261B2 (en) 2018-07-04
CA2881267A1 (en) 2014-02-13
EP2882413A2 (en) 2015-06-17
ES2668302T3 (en) 2018-05-17
EP3246013A1 (en) 2017-11-22
PT3246013T (en) 2019-10-29
CA2881267C (en) 2021-02-16
FR2994386B1 (en) 2016-06-24
WO2014023895A3 (en) 2014-05-01
ES2751878T3 (en) 2020-04-02
EP3246013B1 (en) 2019-10-09
JP6408667B2 (en) 2018-10-17
JP2015528822A (en) 2015-10-01
JP2018030852A (en) 2018-03-01

Similar Documents

Publication Publication Date Title
HK1206975A1 (en) Inhibition of the adhesion of pathogenic microorganisms by a sucrose stearate and or a sorbitan ester in the cosmetic treatment of cutaneous atopy
ZA201302979B (en) Dianosis and treatment relating to th2 inhibition
IL227193B (en) Plant extracts for the treatment and prevention of infections
HK1206999A1 (en) Ketone bodies and ketone body esters for maintaining or improving muscle power output
GB2478595B (en) Phytocannabinoids in the treatment of glioma
EP2981274A4 (en) Probiotic strains for use in treatment or prevention of osteoporosis
SG10201710473VA (en) Combination of vaccination and inhibition of the pd-1 pathway
ZA201300612B (en) Novel bacteria and methods of use thereof
SG2014011746A (en) Nanostructured articles and methods to make the same
GB201217296D0 (en) Method of treatment and/or prevention
EP2872208A4 (en) Sleep assistance article and related methods of use
HUE038336T2 (en) Modified gram positive bacteria and uses thereof
EP2914174A4 (en) Sensor systems and methods of using the same
ZA201304355B (en) Novel bacterium and extracts of said bacterium and the same in dermatology
SG11201504542PA (en) Probiotic strains for the treatment and/or prevention of diarrhœa
GB201302656D0 (en) A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system
GB201115992D0 (en) Inhibitors of Nox4 expression and/or Nox4 function and their use in the prevention and treatment of nerve injury and/or neuropathic pain
HK1209639A1 (en) Gpbp-1 inhibition and its therapeutic use gpbp-1
PT2836612T (en) Novel pseudomonas fluorescens strain and uses thereof in the biological control of bacterial or fungal diseases
EP3027734B8 (en) Isolated microorganism strain lactobacillus plantarum tak 59 ncimb42150 and its use
GB201219678D0 (en) Ketone body inhibitors and uses thereof
HUE038830T2 (en) Modified gram positive bacteria and uses thereof
WO2012097121A9 (en) Specific nnos inhibitors for the therapy and prevention of human melanoma
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
LT2914754T (en) New strain of lactobacillus delbrueckii bacteria and its use for the production of bee pollen